{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T23:33:26Z","timestamp":1776814406224,"version":"3.51.2"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2008,10,7]],"date-time":"2008-10-07T00:00:00Z","timestamp":1223337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2008,10,7]],"date-time":"2008-10-07T00:00:00Z","timestamp":1223337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1007\/s10637-008-9179-3","type":"journal-article","created":{"date-parts":[[2008,10,6]],"date-time":"2008-10-06T15:00:55Z","timestamp":1223305255000},"page":"327-337","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Synthesis and in vitro cytotoxic evaluation of novel diazaspiro bicyclo hydantoin derivatives in human leukemia cells: A SAR study"],"prefix":"10.1007","volume":"27","author":[{"given":"C. S.","family":"Ananda Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. V.","family":"Kavitha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Vinaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. B. Benaka","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. R.","family":"Thimmegowda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Chandrappa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sathees C.","family":"Raghavan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. S.","family":"Rangappa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,10,7]]},"reference":[{"key":"9179_CR1","doi-asserted-by":"crossref","unstructured":"Canadian Cancer Society-National Cancer Institute of Canada Canadian Cancer Statistics (2005) Toronto, Canada, April 2005, ISSN: 0835-2976","DOI":"10.1093\/jncimonographs\/lgi013"},{"key":"9179_CR2","unstructured":"American Cancer Society Cancer Facts and Figures (2006) Atlanta: American Cancer Society, 2006"},{"key":"9179_CR3","doi-asserted-by":"publisher","first-page":"4805","DOI":"10.1021\/jm030183a","volume":"46","author":"J Robert","year":"2003","unstructured":"Robert J, Jarry C (2003) Multidrug resistance reversal agents. J Med Chem 46:4805\u20134817. doi:10.1021\/jm030183a","journal-title":"J Med Chem"},{"key":"9179_CR4","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1021\/jm0408565","volume":"48","author":"IG Monterrey","year":"2005","unstructured":"Monterrey IG, Santell G, Campiglia P, Califano D, Falasconi F, Pisano C et al (2005) Synthesis and cytotoxic evaluation of novel spirohydantoin derivatives of the dihydrothieno[2,3-b]naphtho-4,9-dione System. J Med Chem 48:1152\u20131157. doi:10.1021\/jm0408565","journal-title":"J Med Chem"},{"key":"9179_CR5","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S0928-0987(00)00200-1","volume":"12","author":"MML Fiallo","year":"2001","unstructured":"Fiallo MML, Kozlowski H, Suillerot AG (2001) Mitomycin antitumor compounds Part 1. C D studies on their molecular structure. Eur J Pharm Sci 12:487\u2013494. doi:10.1016\/S0928-0987(00)00200-1","journal-title":"Eur J Pharm Sci"},{"key":"9179_CR6","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.bmcl.2004.12.007","volume":"15","author":"D Potin","year":"2005","unstructured":"Potin D, Launay M, Nicolai E, Fabreguette M, Malabre P, Caussade F et al (2005) De novo design, synthesis, and in vitro activity of LFA-1 antagonists based on a bicyclic[5.5]hydantoin scaffold. Bioorg Med Chem Lett 15:1161\u20131164. doi:10.1016\/j.bmcl.2004.12.007","journal-title":"Bioorg Med Chem Lett"},{"key":"9179_CR7","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1016\/j.bmcl.2005.12.074","volume":"16","author":"J Lee","year":"2006","unstructured":"Lee J, Kim J, Koh JS, Chung HH, Kim KH (2006) Hydantoin derivatives as non-peptidic inhibitors of Ras farnesyl transferase. Bioorg Med Chem Lett 16:1954\u20131956. doi:10.1016\/j.bmcl.2005.12.074","journal-title":"Bioorg Med Chem Lett"},{"key":"9179_CR8","doi-asserted-by":"publisher","first-page":"4021","DOI":"10.1016\/j.bmcl.2006.05.010","volume":"16","author":"C Carmi","year":"2006","unstructured":"Carmi C, Cavazzoni A, Zuliani V, Lodola A, Bordi F, Plazzi PV (2006) 5-Benzylidene-hydantoins as new EGFR inhibitors with antiproliferative activity. Bioorg Med Chem Lett 16:4021\u20134025. doi:10.1016\/j.bmcl.2006.05.010","journal-title":"Bioorg Med Chem Lett"},{"issue":"8","key":"9179_CR9","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.jfluchem.2006.06.007","volume":"127","author":"KL Kirk","year":"2006","unstructured":"Kirk KL (2006) Fluorine in medicinal chemistry: recent therapeutic applications of fluorinated small molecules. J Fluor Chem 127(8):1013\u20131029. doi:10.1016\/j.jfluchem.2006.06.007","journal-title":"J Fluor Chem"},{"issue":"14","key":"9179_CR10","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.2174\/156802606777951073","volume":"6","author":"KL Kirk","year":"2006","unstructured":"Kirk KL (2006) Selective fluorination in drug design and development: an overview of biochemical rationales. Curr Top Med Chem 6(14):1447\u20131456. doi:10.2174\/156802606777951073","journal-title":"Curr Top Med Chem"},{"key":"9179_CR11","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1126\/science.1131943","volume":"317","author":"K Mueller","year":"2007","unstructured":"Mueller K, Faeh C, Diederich F (2007) Fluorine in pharmaceuticals: looking beyond intuition. Science 317:1881\u20131886. doi:10.1126\/science.1131943","journal-title":"Science"},{"key":"9179_CR12","first-page":"38","volume":"4","author":"J Swinson","year":"2007","unstructured":"Swinson J (2007) Fully functional fluorine. Pharmachem 4:38\u201341","journal-title":"Pharmachem"},{"key":"9179_CR13","first-page":"83","volume":"(301\u2013302)","author":"J-P Begue","year":"2006","unstructured":"Begue J-P, Bonnet-Delpon D (2006) Fluorine: an invaluable tool in medicinal chemistry. Actual Chim (301\u2013302):83\u201387","journal-title":"Actual Chim"},{"key":"9179_CR14","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jfluchem.2006.01.011","volume":"127","author":"C Isanbor","year":"2006","unstructured":"Isanbor C, O\u2019Hagan D (2006) Fluorine in medicinal chemistry: a review of anti-cancer agents. J Fluor Chem 127:303\u2013319. doi:10.1016\/j.jfluchem.2006.01.011","journal-title":"J Fluor Chem"},{"key":"9179_CR15","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s10637-008-9130-7","volume":"26","author":"S Chandrappa","year":"2008","unstructured":"Chandrappa S, Benaka Prasad SB, Vinaya K, Ananda Kumar CS, Thimmegowda NR, Rangappa KS (2008) Synthesis and in vitro antiproliferative activity against human cancer cell lines of novel 5-(4-methyl-benzylidene)-thiazolidine-2,4-diones. Invest New Drugs 26:437\u2013444. doi:10.1007\/s10637-008-9130-7","journal-title":"Invest New Drugs"},{"key":"9179_CR16","doi-asserted-by":"publisher","unstructured":"Ananda Kumar CS, Benaka Prasad SB, Vinaya K, Chandrappa S, Thimmegowda NR, Ranganatha SR, Sanjay Swarup, Rangappa KS (2008) Synthesis and antiproliferative activity of substituted diazaspiro hydantoins: a SAR study. Invest New Drugs. doi:10.1007\/s10637-008-9150-3","DOI":"10.1007\/s10637-008-9150-3"},{"key":"9179_CR17","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00044-007-9022-y","volume":"16","author":"CS Ananda Kumar","year":"2007","unstructured":"Ananda Kumar CS, Nanjunda Swamy S, Thimmegowda NR, Benaka Prasad SB, Yip GW, Rangappa KS (2007) Synthesis and evaluation of 1-benzhydryl-sulfonyl-piperazine derivatives as inhibitors of MDA-MB-231 human breast cancer cell proliferation. Med Chem Res 16:179\u2013187. doi:10.1007\/s00044-007-9022-y","journal-title":"Med Chem Res"},{"key":"9179_CR18","doi-asserted-by":"publisher","first-page":"269","DOI":"10.2174\/157340607780620699","volume":"3","author":"C Anil Kumar","year":"2007","unstructured":"Anil Kumar C, Nanjunda Swamy S, Gaonkar SL, Basappa, Bharathi PS, Rangappa KS (2007) N-substituted-2-butyl-5-chloro-3H-imidazole-4-carbalderhyde derivatives as anti-tumor agents against ehrilch ascites tumor cells in vivo. Med Chem 3:269\u2013276. doi:10.2174\/157340607780620699","journal-title":"Med Chem"},{"key":"9179_CR19","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s10637-006-9033-4","volume":"25","author":"C Anil Kumar","year":"2007","unstructured":"Anil Kumar C, Jayarama S, Basappa, Bharathi PS, Rangappa KS (2007) Pro-apoptotic activity of imidazole derivatives mediated by up-regulation of Bax and activation of CAD in Ehrlich ascites tumor cells. Invest New Drugs 25:343\u2013350. doi:10.1007\/s10637-006-9033-4","journal-title":"Invest New Drugs"},{"key":"9179_CR20","doi-asserted-by":"crossref","unstructured":"Alonso ER, Tehrani KA, Boelens M, De Kimpe N (2005) Hydride-promoted ring expansion of 2-azaspiropyrrolinium salts: an approach towards the synthesis of nitramine. Synlett 1726\u20131729","DOI":"10.1055\/s-2005-871555"},{"key":"9179_CR21","first-page":"291","volume":"140","author":"HT Bucherer","year":"1934","unstructured":"Bucherer HT, Steiner W (1934) Syntheses of hydantoins. I. Reactions of \u03b1-hydroxy and \u03b1-amino nitriles. J Prakt Chem 140:291\u2013316","journal-title":"J Prakt Chem"},{"key":"9179_CR22","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1021\/cr60145a001","volume":"46","author":"E Ware","year":"1950","unstructured":"Ware E (1950) The chemistry of hydantoins. Chem Rev 46:403\u2013470. doi:10.1021\/cr60145a001","journal-title":"Chem Rev"},{"key":"9179_CR23","doi-asserted-by":"publisher","first-page":"7650","DOI":"10.1021\/jo961594k","volume":"61","author":"CL Wysong","year":"1996","unstructured":"Wysong CL, Yokum TS, Morales GA, Gundry Rl, McLaughlin ML, Hammer RP (1996) 4-Aminopiperidine-4-carboxylic acid: cyclic A. a, a-disubstituted amino acid for preparation of water soluble highly helical peptides. J Org Chem 61:7650\u20137651","journal-title":"J Org Chem"},{"issue":"1\u20132","key":"9179_CR24","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65(1\u20132):55\u201363. doi:10.1016\/0022-1759(83)90303-4","journal-title":"J Immunol Methods"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-008-9179-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10637-008-9179-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-008-9179-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-008-9179-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T21:26:01Z","timestamp":1744147561000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10637-008-9179-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,7]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["9179"],"URL":"https:\/\/doi.org\/10.1007\/s10637-008-9179-3","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,7]]},"assertion":[{"value":"8 August 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2008","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2008","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}